Autologous adipose tissue-derived mesenchymal stem cell (EHL Bio)

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameAutologous adipose tissue-derived mesenchymal stem cell (EHL Bio)
Drug Alias NameADSTEM injection (EHL Bio)Autologous mesenchymal stem cell therapy (EHL Bio)
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionStem cells stimulantsStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEhl Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEhl Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A